There is abundant evidence to suggest that abnormalities of glycoproteins occur in patients with cystic fibrosis.' Some of these features may be secondary effects, for example the changed density and solubility of glycoproteins in cystic fibrosis are probably attributable to increased Ca2+ concentration.23 However, differences in the sugar content might reflect a constitutional defect in glycosylation. De- creased fucose or increased sialic acid or both have been reported in duodenal fluid, pulmonary secretions, and rectal mucus, on the serum proteins which bind heparin, mucus glycopeptides from meconium, and decreased sialic acid and altered binding to lectins have been reported for serum a2-macroglobulin.' "4 Although there have been conflicting reports, these observations suggest a generalised defect in soluble glycoproteins possibly involving their processing. The possible role of the cell membrane in the pathogenesis of cystic fibrosis has led to a number of studies on the cell membrane glycoproteins and has provided some evidence for alterations of these components in fibroblasts,7-9 although several other studies failed to show differences.'014 The purpose of this study was to investigate the glycan structure of soluble and membrane glycoproteins in cystic fibrosis patients, heterozygotes, and controls, using a wide variety of lectins to detect the glycoproteins after electrophoresis, employing the f3eneral technique originally described by Burridge' and (table 2) . No reproducible differences between the patient and control samples were seen using either sialidase treated or untreated material, although in one IF experiment (fig 2) a component (indicated with an arrow) was detected with RCA-I in sialidase treated samples from three patients but not in the controls. However, a similar component was weakly visible in the control material after prolonged exposure (3 days) of the autoradiograph and, furthermore, was not visible on subsequent examination of the same material from the patients and controls or in several other cases.
RED CELL MEMBRANE GLYCOPROTEINS
There were no differences in glycoprotein profiles between the cystic fibrosis patients and the controls. However, some differences in staining were seen with the blood group reactive lectins, UEA-I and HPA, which appeared to be related to the different blood groups of the subjects analysed. HPA showed strong binding to the glycoproteins of A1 subjects and UEA-I to the glycoproteins of type 0 subjects. These observations are compatible with those of Finne. 19 Quite surprisingly sucWGA and WGA after sialidase treatment also distinguished the red cell membrane glycoproteins from persons of different blood groups. They bind strongly to those of blood group A1 but weakly or not at all to those of blood groups B and 0. Fig 3 shows an example of the variety of patterns that may be observed with these lectins.
GLYCOPROTEINS IN FIBROBLAST MEMBRANES
Membrane-rich extracts of fibroblasts, both treated and untreated with sialidase, from six cystic fibrosis patients were examined using up to nine different lectins after SDS-PAGE ( 
